NCT02014727 - Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

July 31, 2015

Conditions

Malaria, Falciparum

Interventions

BIOLOGICAL

Group A1 : 50µg AMA1-DiCo + Alhydrogel

BIOLOGICAL

Group A2 : 50 µg AMA1-DiCo+ GLA-SE

BIOLOGICAL

Group B2 : Placebo

Trial Locations (2)

CIC BT 505 de vaccinologie Cochin Pasteur, Hôpital Cochin Bâtiment Lavoisier 27 Rue Du Faubourg Saint Jacqu

CNRFP, Ouagadougou